- $78.71m
- $96.22m
- $103.46m
- 21
- 41
- 41
- 26
Annual income statement for Agenus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 88.2 | 296 | 98 | 156 | 103 |
| Cost of Revenue | |||||
| Gross Profit | 85.8 | 292 | 87.5 | 153 | 103 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 208 | 264 | 279 | 316 | 224 |
| Operating Profit | -120 | 31.9 | -181 | -160 | -120 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -183 | -28.7 | -231 | -257 | -232 |
| Net Income After Taxes | -183 | -28.7 | -231 | -257 | -232 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -181 | -23.9 | -220 | -246 | -227 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -181 | -24.1 | -220 | -246 | -227 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -20.7 | -2.65 | -15.5 | -13.7 | -10.8 |